The Latest
-
CVS CEO says Aetna has a handle on medical costs in advance of Q2 earnings
David Joyner’s assurances, which come about a month before CVS is scheduled to report its second quarter results, will likely be welcomed by investors wary after a difficult few years for insurers.
-
Sponsored by Greenway Health
The automated practice: A survival strategy for independent healthcare
Why automation is becoming essential for independent practice survival.
-
Strikes boil at Mass General Brigham, Mount Nittany
About 4,500 workers at Mass General Brigham are striking this week, while employees at Mount Nittany Medical Center in Pennsylvania said they would take to the picket line later this month.
-
Whistleblower lawsuit accuses Alignment of accounting fraud
A former executive is claiming that the MA insurer recorded millions of dollars as capital expenditures that should have been operating expenses, inflating its value. Alignment strongly denied the allegations.
-
Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey
“We have all this data that’s available, but it’s actually not actionable because we don’t have a way to get it into clinical workflow,” said American Medical Association CEO Dr. John Whyte.
-
Resmed to sell software business MatrixCare to private equity firm
Selling the unit, which provides an EHR for post-acute care, will allow the respiratory device maker to shift more resources to faster-growing parts of its portfolio.
-
Centene exits Arkansas Medicaid expansion program, citing funding challenges
ARHOME represents a small portion of Centene’s overall membership and premiums. But the exit shows how insurers are rejigging their businesses in advance of Medicaid work requirements, one analyst said.
-
External audit of UnitedHealth senior home visits finds most diagnoses supported by medical data
Almost 97% of diagnoses found in HouseCalls visits were backed up by patients’ medical records, vindicating the program’s integrity, UnitedHealth said.
-
ACA premiums set to spike again in 2027
Insurers are proposing a median premium increase of 14% for 2027, according to KFF, suggesting another year of double-digit premium hikes as policy upheaval and rising costs continue to roil the marketplaces.
-
Ascension to buy Tennessee system Williamson Health in $1B deal
Ascension beat out other offers, including from HCA and Optum, to give Williamson a financial lifeline amid serious challenges facing regional hospital operators. The deal is expected to be final by 2028 at the latest.
-
Epic president to step down this summer
Sumit Rana’s departure could be a significant leadership shakeup for Epic, as the president was viewed as a potential successor to the EHR vendor’s 82-year-old CEO.
Updated July 8, 2026 -
AdaptHealth discloses patient data was stolen in cyberattack
The medical device supplier said that a threat actor accessed company systems through a social engineering attack.
-
Private equity may skirt oversight with nonprofit healthcare joint ventures
The investment firms are leaning on joint ventures with nonprofits to expand in the healthcare sector, according to a new report from the Private Equity Stakeholder Project.
-
Opinion
Healthcare faces congressional oversight heading into 2026 midterms and beyond
Democrats are planning investigations into major healthcare topics if they win majorities in Congress this November. Healthcare firms should prepare for increased oversight now, write lawyers with Holland & Knight.
-
Elevance sues CMS after Medicare Advantage stars recalculation
Regulators recalculated plans’ quality scores last month after losing a lawsuit to Clover Health. But they used a different methodology for Clover than its peers, causing Elevance to lose out on $115 million, the insurer told a court.
-
Medtronic starts to notify people affected by cyberattack
The medtech giant said it currently has no evidence that the accessed data has been posted to the internet.
-
Medicare slashes 340B payments, broadens site-neutral policies in proposed 2027 payment rule
The rule, released Thursday, builds on Trump administration’s priorities, including cutting Medicare reimbursement for drugs in the controversial 340B program and equalizing payment between sites of care.
-
Medicare Advantage bonuses will exceed $13B this year, KFF finds
Medicare is spending more on quality bonuses despite fewer enrollees in eligible plans, the health policy research group said — a concerning trend putting more stress on Medicare’s coffers that could amplify calls for reform.
-
Allegheny Health Network, Heritage Valley finalize combination in Pennsylvania
The deal brings Highmark Health-owned AHN’s hospital count to 16. The combined system will invest about $285 million over the next decade to bolster Heritage Valley’s facilities.
-
Court dismisses PBMs’ lawsuit against FTC following insulin settlements
Express Scripts, Caremark and Optum Rx sued the FTC after the agency accused them of driving up the cost of insulin. But the countersuit is being put to bed now that the PBMs are settling with regulators.
-
Fewer health information exchanges say they experience info blocking
Fewer companies appear to be impeding the flow of digital health information, but some could be doing so frequently, the ONC said.
-
AHA taps state advocate as new CEO
Steve Walsh, the CEO of a Massachusetts hospital group, will assume the top role in the early fall, after the AHA’s longtime leader Rick Pollack retires.
-
Nearly 4M Medicare beneficiaries could access GLP-1s for weight loss under new program: analysis
Millions of people could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a report by KFF.
-
States sue Trump administration over Medicaid work requirements rule
Twenty-six states are seeking to overturn some of the regulation released by the CMS this month that outlined Medicaid work requirements — and asking the court to pause implementation for the time being.
-
Top FDA gene and cell therapy regulator to step down
Following Vijay Kumar’s exit, acting CBER Director Karim Mikhail will also oversee a review office that has become a battleground for debates on FDA flexibility.
-
ACA enrollment declines by nearly 3M
ACA plan enrollment continues to shrink following the lapse of more generous subsidies last year, according to new federal data.